https://pharmaceuticalintelligence.com/2026/09/15/novartis-and-bristol-myers-squibb-halt-car-t-trial-for-autoimmune-diseases-over-patient-deaths-a-potential-issue-with-cell-based-manufacturing/ 2026-09-15T13:36:57Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing 2026-09-15T13:36:57Z Blog https://pharmaceuticalintelligence.com/2026/09/15/fda-contemplates-changes-in-trial-design-drug-development-and-use-of-ai-in-clinical-trials/ 2026-09-15T10:52:47Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials 2026-09-15T10:52:47Z Blog https://pharmaceuticalintelligence.com/virtual-data-room-vdr-for-strategic-customized-slide-decks/lpbi-strategic-deck-architecture-june-2026/version-2-0-master-decks-for-slides-in-sections-appendices-and-pointers-to-virtual-data-room/slide-deck-version-2-0-master-deck/speaker_lines_not_for_screen_share-2-0-master-deck/ 2026-09-14T15:55:37Z Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA en Speaker_Lines_NOT_FOR_SCREEN_SHARE - 2.0 Master Deck 2026-09-13T22:03:27Z Blog